retatrutide triple agonist phase 2 nejm 2023 obesity results 💉 may be redefining treatment. New data from TRIUMPH-1 Trial showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Retatrutide vs Ozempic: Clinical Trial

J Diabetes 7:584588 Wen B, Zhao L, Zhao H, Wang X (2018) Liraglutide exerts a bone-protective effect in ovariectomized rats with streptozotocin-induced diabetes by inhibiting osteoclastogenesis

Benefits: Mimics the same GLP-1 effects as injections, helping you manage portions and cravings

Y.LinY.KoY

Enhanced with skin brighteners of Niacinamide, Kojic

Effects of medium- and long-chain structured triacylglycerol on the therapeutic efficacy of vitamin D on ulcerative colitis: a consideration for efficient lipid delivery systems

It contains 0.9 percent benzyl alcohol as a preservative, which inhibits bacterial growth and extends the shelf life of your reconstituted peptide